Location: Home
  • search
  • go
  • Relate News
  • 7/19/2024NHSA: DRG Grouping V2.0 to Be Released, Policy Tilt Towards Innovative...
  • 7/19/2024CDE Solicits Public Comments on the Technical Guidelines for In Vitro ...
  • 7/19/2024Beijing to Build International Pharma Innovation Park
  • 7/19/2024Chinese and Visiting Japanese Top Healthcare Officials Agree to Promot...
  • 7/19/2024Recent Executive Moves
  • 7/19/2024Experts Predict Novo Victory in Grueling Chinese Patent Case (MedWatcj...
  • 7/18/2024NMPA Solicits Public Comments on Drafts of the 'GMP for Pharmaceutical...
  • 7/18/2024NMPA Suspends Import, Sales and Use of Daiwoong's Cefodizime Sodium fo...
  • 7/18/2024India's Pharma Contract Manufacturing Sector Set to Double in Three Ye...
  • 7/18/2024Marinus's Ganaxolone Approved in China as First Treatment for Seizures...
  • 7/18/2024Merck Unveils GMP-Compliant Cell Culture Media Manufacturing Line in C...
  • 7/18/2024China Sets Up National Working Group to Standardize Healthcare Securit...
  • 7/17/2024Full-Life Tech, SK Biopharma Enter Licensing Deal for Novel Therapeuti...
  • 7/17/2024SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to E...
  • 7/17/2024Green Cross Sells Hong Kong Unit to China Resources Boya Bio
  • 7/17/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...
  • 7/17/2024CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
  • 7/17/2024CDE Issues the Technical Guidelines for Clinical Trials of Drugs for G...
  • 7/16/2024NMPA Announces Package Insert Revision of Spleen Polypeptide Injection...
  • 7/16/2024U.S. Senators Introduce Bill to Reduce U.S. Dependence on China for Ph...
  • 7/16/2024Who Will Acquire Legend Bio for 13B to 15B USD? Could It Be J&J? (Drug...
  • 7/16/2024China's Health Supplements Market: Trends and Opportunities for Busine...
  • 7/15/2024China's Fast-following Approach Positions It at the Forefront of the F...
  • 7/15/2024China Biopharma Tracker – H1/2024 (PharmaNJ)
  • 7/15/2024Will US Clinical Study Diversity Guidance Cloud Chinese Firms' Prospec...
  • 7/15/2024China's Once-booming Online Healthcare Sector Sees Its Vital Signs Sin...
  • 7/15/2024CDE Solicits Comments on the Technical Guidelines for IVRT and IVPT St...
  • 7/15/2024Domestic Developers File for China's First Home-Made Quadrivalent HPV ...
  • 7/15/2024GenScript's US Unit Legend Biotech Reportedly Receives Takeover Approa...
  • 7/12/2024AFT in China Distribution Deal with Hainan Haiyao for Skin Infection C...
  • Page:57/775 Total number of articles:23222: [First][<<] [55] [56] [57] [58] [59] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group